Home » Topics » BioWorld Science

BioWorld Science
RSS

MFN2 agonist restores mitochondrial trafficking in models of Charcot-Marie-Tooth disease type 2A

May 11, 2018

Pharmasum Therapeutics identifies novel DYRK inhibitors

May 11, 2018

Novel PTP-2C inhibitors discovered at DE Shaw Research, Relay Therapeutics

May 11, 2018

Patient recruitment ongoing in phase I trial of PF-06821497

May 11, 2018

Prelude Therapeutics discovers PRMT5 inhibitors

May 11, 2018

Novel P2X purinoceptor 7 antagonists discovered at Shionogi

May 11, 2018

Positive topline data from phase I trial of prophylactic CMV vaccine candidate VBI-1501

May 11, 2018

Lundbeck identifies novel phosphodiesterase PDE1 inhibitors

May 11, 2018

Nimbus Lakshmi patents novel TYK2 inhibitors

May 11, 2018

Novel liver X receptor beta agonists divulged by Merck & Co.

May 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...